BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38355400)

  • 1. Synthesis and Evaluation of Natural and Unnatural Tetrahydrocannabiorcol for Its Potential Use in Neuropathologies.
    Anand R; Anand LK; Rashid N; Painuli R; Malik F; Singh PP
    J Nat Prod; 2024 Feb; 87(2):167-175. PubMed ID: 38355400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Δ
    Anchesi I; Schepici G; Chiricosta L; Gugliandolo A; Salamone S; Caprioglio D; Pollastro F; Mazzon E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
    Carroll CB; Zeissler ML; Hanemann CO; Zajicek JP
    Neuropathol Appl Neurobiol; 2012 Oct; 38(6):535-47. PubMed ID: 22236282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and Characterization of Impurities in Commercially Marketed Δ
    Radwan MM; Wanas AS; Gul W; Ibrahim EA; ElSohly MA
    J Nat Prod; 2023 Apr; 86(4):822-829. PubMed ID: 36827690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ
    Hoffman AF; Lycas MD; Kaczmarzyk JR; Spivak CE; Baumann MH; Lupica CR
    Addict Biol; 2017 Mar; 22(2):390-399. PubMed ID: 26732435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional effects of synthetic cannabinoids versus Δ
    Schreiber S; Bader M; Lenchinski T; Meningher I; Rubovitch V; Katz Y; Cohen E; Gabet Y; Rotenberg M; Wolf EU; Pick CG
    Addict Biol; 2019 May; 24(3):414-425. PubMed ID: 29423994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication.
    Balster RL; Prescott WR
    Neurosci Biobehav Rev; 1992; 16(1):55-62. PubMed ID: 1313164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Δ
    Schafroth MA; Mazzoccanti G; Reynoso-Moreno I; Erni R; Pollastro F; Caprioglio D; Botta B; Allegrone G; Grassi G; Chicca A; Gasparrini F; Gertsch J; Carreira EM; Appendino G
    J Nat Prod; 2021 Sep; 84(9):2502-2510. PubMed ID: 34304557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus- and open-field effects of the enantiomers of 11-hydroxy-delta-8-tetrahydrocannabinol in pigeons and gerbils.
    Järbe TU; Mechoulam R; Zahalka J
    Pharmacol Biochem Behav; 1994 Jan; 47(1):113-9. PubMed ID: 8115412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
    Wiley JL; Marusich JA; Lefever TW; Grabenauer M; Moore KN; Thomas BF
    Neuropharmacology; 2013 Dec; 75():145-54. PubMed ID: 23916483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal
    Linciano P; Citti C; Luongo L; Belardo C; Maione S; Vandelli MA; Forni F; Gigli G; Laganà A; Montone CM; Cannazza G
    J Nat Prod; 2020 Jan; 83(1):88-98. PubMed ID: 31891265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering the psychoactivity of a cannabinoid from liverworts associated with a legal high.
    Chicca A; Schafroth MA; Reynoso-Moreno I; Erni R; Petrucci V; Carreira EM; Gertsch J
    Sci Adv; 2018 Oct; 4(10):eaat2166. PubMed ID: 30397641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice.
    Darmani NA
    Pharmacol Biochem Behav; 2001 Feb; 68(2):311-7. PubMed ID: 11267636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Δ
    Gatch MB; Forster MJ
    Psychopharmacology (Berl); 2018 Mar; 235(3):673-680. PubMed ID: 29138877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
    Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
    Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine.
    Pertwee RG; Stevenson LA; Elrick DB; Mechoulam R; Corbett AD
    Br J Pharmacol; 1992 Apr; 105(4):980-4. PubMed ID: 1324060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Potential Anxiolytic Effects of Minor Cannabinoids and Terpenes After Acute and Chronic Oral Administration in Rats.
    Jenkins BW; Moore CF; Covey D; McDonald JD; Lefever TW; Bonn-Miller MO; Weerts EM
    Cannabis Cannabinoid Res; 2023 Sep; 8(S1):S11-S24. PubMed ID: 37721993
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.
    Martin BR; Compton DR; Thomas BF; Prescott WR; Little PJ; Razdan RK; Johnson MR; Melvin LS; Mechoulam R; Ward SJ
    Pharmacol Biochem Behav; 1991 Nov; 40(3):471-8. PubMed ID: 1666911
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.